-+ 0.00%
-+ 0.00%
-+ 0.00%

Moleculin Biotech Q3 EPS $(9.59) Misses $(8.53) Estimate

Benzinga·11/16/2026 12:36:30
Listen to the news
Moleculin Biotech (NASDAQ:MBRX) reported quarterly losses of $(9.59) per share which missed the analyst consensus estimate of $(8.53) by 12.43 percent. This is a 43.59 percent increase over losses of $(17.00) per share from the same period last year.